1. Kemp CG, Pence BW, Velloza J, Concepcion T, et al.
   Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
   AIDS 2024.
   


2. Migisha R, Chen G, Muyindike WR, Aung TN, et al.
   Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
   AIDS 2024.
   


3. Haw NJL, Lesko CR, Ng DK, Lam J, et al.
   Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
   AIDS 2024.
   


4. Cholli PA, Buchacz KM, Harris NS, Crim SM, et al.
   Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
   AIDS 2024.
   


5. Hu FH, Tang XL, Ge MW, Jia YJ, et al.
   Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
   AIDS 2024.
   


6. Lan C, Zhu B, Hailong Z, Yuting S, et al.
   Near Full-Length Genome Characterization of two Novel Unique Recombinants (CRF01_AE/CRF07_BC) in Beijing, China.
   AIDS Res Hum Retroviruses 2024.
   


7. Le Brazidec DL, Cormier K, Almonte A, Napoleon S, et al.
   Pre-Exposure Prophylaxis Care Cascade Among Men Who Have Sex with Men Engaging in Partner Notification Services at a Sexually Transmitted Infections Clinic.
   AIDS Res Hum Retroviruses 2024.
   


8. Valin N, Lambert-Niclot S, Torres E, Meynard JL, et al.
   A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
   Clin Infect Dis 2024.
   


9. Nguyen Q, Wooten D, Lee D, Moreno M, et al.
   GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
   Clin Infect Dis 2024.
   


10. Hazra A, Celum C, Luetkemeyer AF, Molina JM, et al.
    Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
    Clin Infect Dis 2024.
    


11. Kenyon C.
    We should not downplay the risks that doxycycline PEP will select for AMR.
    Clin Infect Dis 2024.
    


12. Boodman C, Gupta N, Nelson CA, van Griensven J, et al.
    Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
    Clin Infect Dis 2024;78:554-561.
    


13. Krishnan S, Chaisson RE.
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis 2024;78:514-517.
    


14. Vanbaelen T, Tsoumanis A, Kenyon C.
    Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Clin Infect Dis 2024;78:803-805.
    


15. Sheth AN, Momplaisir F, Dumond JB.
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA 2024;331:912-914.
    


16. Erenrich RK, Braun RA, Torres-Mendoza DM, Stevenson OL, et al.
    Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention.
    J Acquir Immune Defic Syndr 2024;95:463-469.
    


17. Zeeb M, Frischknecht P, Huber M, Schenkel CD, et al.
    Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
    J Infect Dis 2024.
    


18. Wang Z.
    Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile.
    J Med Virol 2024;96:e29553.
    


19. Trunfio M, Tang B, Okwuegbuna O, Iudicello JE, et al.
    Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers.
    J Med Virol 2024;96:e29550.
    


20. von Maltitz P, Wettstein L, Weil T, Schommers P, et al.
    Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
    J Virol 2024.
    


21. Twentyman J, Emerman M, Ohainle M.
    Capsid-dependent lentiviral restrictions.
    J Virol 2024.
    


22. Watts G.
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet 2024.
    

Display articles in

• Abstract format
• Medline format